NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 245 filers reported holding NEOGENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $13,230,243 | -10.3% | 953,875 | +1.7% | 0.00% | 0.0% |
Q1 2024 | $14,743,030 | -7.7% | 937,852 | -5.0% | 0.00% | 0.0% |
Q4 2023 | $15,971,327 | +31.4% | 987,103 | -0.1% | 0.00% | 0.0% |
Q3 2023 | $12,150,728 | -26.6% | 987,864 | -4.2% | 0.00% | 0.0% |
Q2 2023 | $16,564,122 | -10.3% | 1,030,748 | -2.9% | 0.00% | -25.0% |
Q1 2023 | $18,476,188 | +85.5% | 1,061,240 | -1.5% | 0.00% | +100.0% |
Q4 2022 | $9,958,705 | +4.8% | 1,077,782 | -2.3% | 0.00% | 0.0% |
Q3 2022 | $9,501,000 | +10.7% | 1,103,581 | +4.8% | 0.00% | 0.0% |
Q2 2022 | $8,584,000 | -40.4% | 1,053,171 | -11.1% | 0.00% | -33.3% |
Q1 2022 | $14,400,000 | -69.6% | 1,185,209 | -14.7% | 0.00% | -66.7% |
Q4 2021 | $47,409,000 | -30.7% | 1,389,489 | -2.0% | 0.01% | -30.8% |
Q3 2021 | $68,417,000 | +8.9% | 1,418,236 | +2.0% | 0.01% | +8.3% |
Q2 2021 | $62,816,000 | -7.5% | 1,390,657 | -1.2% | 0.01% | -14.3% |
Q1 2021 | $67,917,000 | -10.5% | 1,408,172 | -0.1% | 0.01% | -17.6% |
Q4 2020 | $75,917,000 | +46.2% | 1,410,039 | +0.2% | 0.02% | +30.8% |
Q3 2020 | $51,935,000 | +18.1% | 1,407,856 | -0.9% | 0.01% | +8.3% |
Q2 2020 | $43,991,000 | +9.1% | 1,419,982 | -2.8% | 0.01% | -7.7% |
Q1 2020 | $40,325,000 | -9.9% | 1,460,560 | -4.6% | 0.01% | +8.3% |
Q4 2019 | $44,778,000 | +57.2% | 1,530,925 | +2.8% | 0.01% | +50.0% |
Q3 2019 | $28,483,000 | -15.6% | 1,489,724 | -3.1% | 0.01% | -11.1% |
Q2 2019 | $33,733,000 | -9.9% | 1,537,485 | -16.0% | 0.01% | -10.0% |
Q1 2019 | $37,446,000 | +279.4% | 1,830,240 | +133.8% | 0.01% | +233.3% |
Q4 2018 | $9,870,000 | -27.1% | 782,790 | -11.3% | 0.00% | 0.0% |
Q3 2018 | $13,543,000 | +47.6% | 882,244 | +26.0% | 0.00% | +50.0% |
Q2 2018 | $9,177,000 | +59.9% | 700,072 | -0.5% | 0.00% | 0.0% |
Q1 2018 | $5,740,000 | -20.8% | 703,512 | -14.0% | 0.00% | 0.0% |
Q4 2017 | $7,249,000 | -33.7% | 818,196 | -16.7% | 0.00% | -33.3% |
Q3 2017 | $10,935,000 | +29.3% | 982,560 | +4.1% | 0.00% | +50.0% |
Q2 2017 | $8,456,000 | +36.9% | 943,784 | +20.5% | 0.00% | 0.0% |
Q1 2017 | $6,178,000 | -16.3% | 783,011 | -9.1% | 0.00% | 0.0% |
Q4 2016 | $7,385,000 | +0.1% | 861,720 | -4.0% | 0.00% | 0.0% |
Q3 2016 | $7,380,000 | +13.3% | 897,824 | +10.8% | 0.00% | 0.0% |
Q2 2016 | $6,514,000 | +158.1% | 810,167 | +116.4% | 0.00% | +100.0% |
Q1 2016 | $2,524,000 | -0.9% | 374,361 | +15.7% | 0.00% | 0.0% |
Q4 2015 | $2,547,000 | +175.4% | 323,630 | +100.6% | 0.00% | – |
Q3 2015 | $925,000 | -29.5% | 161,300 | -33.5% | 0.00% | – |
Q2 2015 | $1,312,000 | +216.1% | 242,605 | +173.1% | 0.00% | – |
Q1 2015 | $415,000 | +3.8% | 88,844 | -7.4% | 0.00% | – |
Q4 2014 | $400,000 | -30.4% | 95,916 | -13.1% | 0.00% | – |
Q3 2014 | $575,000 | +159.0% | 110,327 | +64.3% | 0.00% | – |
Q2 2014 | $222,000 | -50.3% | 67,148 | -47.9% | 0.00% | – |
Q1 2014 | $447,000 | -5.3% | 128,846 | -1.1% | 0.00% | – |
Q4 2013 | $472,000 | -20.5% | 130,293 | -34.1% | 0.00% | – |
Q3 2013 | $594,000 | +50.8% | 197,730 | +99.3% | 0.00% | – |
Q2 2013 | $394,000 | – | 99,191 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 1,615,513 | $13,166,000 | 9.25% |
First Light Asset Management, LLC | 2,715,487 | $22,131,000 | 2.58% |
PERKINS CAPITAL MANAGEMENT INC | 202,550 | $1,651,000 | 1.71% |
Greenhouse Funds LLLP | 1,395,035 | $11,370,000 | 1.25% |
EMERALD ADVISERS, LLC | 1,213,353 | $9,889,000 | 0.51% |
Bullseye Asset Management LLC | 108,272 | $883,000 | 0.50% |
EMERALD MUTUAL FUND ADVISERS TRUST | 959,858 | $7,823,000 | 0.45% |
OAK FAMILY ADVISORS, LLC | 88,604 | $722,000 | 0.36% |
MPM BioImpact LLC | 135,573 | $1,105,000 | 0.31% |
Fernwood Investment Management, LLC | 70,285 | $573,000 | 0.25% |